药物对比
Dapagliflozin vs Sotagliflozin
Dapagliflozin 与 Sotagliflozin 对比：用于2型糖尿病、心力衰竭和慢性肾脏病的SGLT2抑制剂与SGLT1/2双重抑制剂比较。解析疗效、安全性及主要差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises for patients with type 2 diabetes plus heart failure or CKD when weighing selective SGLT2 versus dual SGLT1/SGLT2 inhibition.
结论
Dapagliflozin typically has stronger evidence and fewer GI effects, though sotagliflozin may suit selected patients needing extra intestinal glucose blockade.
全部药物对比